Hebei Can't Dodge $153M Penalty In Vitamin C Class Action

Law360, Los Angeles (November 26, 2013, 4:18 PM EST) -- A New York federal judge on Tuesday refused to toss a $153.3 million award against Hebei Welcome Pharmaceutical Co. Ltd. and North China Pharmaceutical Group Corp. in a class action over vitamin C price-fixing claims, finding a jury wasn't improperly blocked from evidence.

U.S. District Judge Brian M. Cogan decided that Chinese law didn't compel the defendants to engage in the alleged antitrust violations, and thus he wasn't obligated to allow the jury to consider copies of Chinese laws and regulations describing the meaning of related...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.